Tiziana Life Sciences Ltd (TLSA)
NASDAQ: TLSA · Real-Time Price · USD
1.500
-0.070 (-4.46%)
At close: May 12, 2025, 4:00 PM
1.510
+0.010 (0.67%)
After-hours: May 12, 2025, 4:12 PM EDT
Tiziana Life Sciences Employees
Tiziana Life Sciences had 9 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
9
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,318,111
Market Cap
160.36M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
TLSA News
- 9 hours ago - Tiziana Life Sciences Announces Purchase of Shares by Chairman - GlobeNewsWire
- 3 days ago - Tiziana Life Sciences Announces Significant Reduction in Microglia Activation in PET Scan of Moderate Alzheimer's Patient Treated with Intranasal Foralumab - GlobeNewsWire
- 6 days ago - Tiziana Life Sciences Announces Comprehensive Positive Results from Study of Nasal Foralumab in Patients with Multiple Sclerosis - GlobeNewsWire
- 19 days ago - Tiziana Life Sciences Announces University of Massachusetts Commences Dosing Intranasal Foralumab in Phase 2 Multiple Sclerosis Trial - GlobeNewsWire
- 5 weeks ago - Tiziana Life Sciences Announces Johns Hopkins University Commences Dosing Nasal Foralumab in Phase 2 Multiple Sclerosis Clinical Trial - GlobeNewsWire
- 6 weeks ago - Tiziana Life Sciences Announces Yale University Commences Intranasal Foralumab Dosing in Phase 2 Multiple Sclerosis Trial - GlobeNewsWire
- 2 months ago - Tiziana Life Sciences to Present at the 37th Annual Roth Conference - GlobeNewsWire
- 2 months ago - Tiziana Life Sciences Regains Compliance with Nasdaq Listing Minimum Bid Price Rule - GlobeNewsWire